Abzu AI in transportation

All Abzu content.

Our unique perspective of transparency and trust on topics from AI to business to being good humans.

Casper Wilstrup explains the symbolic AI behind Abzu's proprietary QLattice®: An AI that generates explanations along with predictions.
Casper joins EU-Startups podcast not only to talk about the benefits, but also the real challenges of startups building their tech stacks on black-box AI infrastructure, and the issue of uncertainty over upcoming regulations from the EU and other regulatory bodies.
Code camp is a tradition that we hold close to our hearts, not just because we've been doing it for over 5 years, but because it's a very efficient and effective way for us to create and innovate.
We at Abzu had the privilege of being a prominent player in the future of AI in fintech: A journey marked by trust, where we must balance the capabilities of AI with human touch.
We practice pair programming at Abzu, an Agile software development technique that improves our code quality, efficiency, and collaboration.
If we want the financial industry to be considered more trustworthy than it is today, the use of AI in fintech is not off the table. But it calls for a cautious approach – and trustworthy AI.
Christian Lund, co-founder of Templafy, joins the board of directors at Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies.
Casper Wilstrup, a global expert in explainable, trustworthy AI, shares his Top Five Tips For Harnessing AI Technology to Propel People Operations.
Abzu, the Danish/Spanish startup that builds trustworthy AI to tackle complex challenges for the world's leading companies., welcomes Kasper Sommer as its new Chief Financial Officer.
Abzu, the Danish-Spanish startup that builds and applies trustworthy AI to tackle complex challenges for the world’s leading companies, secures ISO 27001:2022 certification, reinforcing its value proposition for explainable, resilient, and safe AI solutions.
Casper Wilstrup, a global expert in explainable, trustworthy AI, tells Jyske Bank TV at Nordic Fintech Week why both the answer and the reasoning behind the answer are important in AI applications.
According to my naturalist view, all stuff — including AIs — has some level of proto-consciousness. However, I’m fairly certain that current AIs aren’t experiencing unified consciousness like we do.
Predicting weight loss success on a new Nordic diet: an untargeted multi-platform metabolomics and machine learning approach.
A novel QLattice-based whitening machine learning model of landslide susceptibility mapping.
Plasma proteomics discovery of mental health risk biomarkers in adolescents.
An enlightening conversation with Marco Salvatore , a pioneer in the use of AI and ML in biomarker discovery and drug development.
Learn how explainable AI is enabling researchers to gain a deeper understanding of complex biological systems, uncover hidden patterns, and make more informed decisions.
Abzu, the Danish / Spanish startup that has introduced new methods and technology to drive discoveries and reduce R&D costs for pharmaceutical and biotech companies, is thrilled to win Best HealthTech at the 2023 Nordic Startup Awards.
Analysis of the relationship between fetal health prediction features with machine learning Feyn QLattice regression model.
Artificial intelligence for diagnosis of mild–moderate COVID-19 using haematological markers.
The application designs RNA therapeutics through parallel hypotheses testing of drug targets and individual antisense oligonucleotide (ASO) drug properties.
Abzu's Jonas Elsborg presents his research with NASA GeneLab: "Elucidating dermatological changes in spaceflight with explainable AI."
Information fusion via symbolic regression: A tutorial in the context of human health.
The TOLAC project brings data-driven insights to expectant parents at important stages of pregnancy to reduce the risk inherent in vaginal or caesarian delivery.
Part 2 on Deep Tech Stories: Casper Wilstrup on self-management and building a transparent organization.
Abzu® announced that the United States Patent and Trademark Office (USPTO) has issued Abzu Aps a patent number US 11,537,686 titled “Method of Deriving a Correlation” that protects the technology behind the pioneering QLattice algorithm.
Launched in collaboration with the Ethical AI Governance Group (EAIGG) and the Ethical AI Database (EAIDB), the Nordic Ethical AI Landscape is the only publicly available, vetted database of AI companies in the Nordics that provide ethical services.
To address the deficiency of treatments for rare diseases, the selected partners in project Elegant North will create a cross-border, rare disease data-sharing platform to foster cross-sector collaboration between researchers, companies, and healthcare systems.
See the Abzu Copenhagen office, and how we manage open-air collaboration, in 3 minutes.
On Deep Tech stories podcast: An interview with Casper Wilstrup on he path to inventing a new kind of AI.
Quantum lattices for early cancer detection through machine learning.
A recap of Abzu's Autumn 2022 Beer, Data, + Drugs: An invite-only event to celebrate working in drug discovery.
Peptomyc used the QLattice and Abzu’s expertise in patient stratification to reveal early predictive response-biomarkers to treatment with OMO-103 in metastatic patients. The analysis by the QLattice was conducted on a very small clinical trial of 22 patients.
On Forward: An interview with Casper Wilstrup for an in-depth intro into Abzu and Abzu's proprietary trustworthy AI technology.
Abzu will be applying the €2.5 million grant to the development of the Abzu AI platform, a user-friendly and easy-to-operate platform built on the QLattice engine that makes interpretable and explainable predictions widely accessible.
Predicting inpatient mortality in patients with inflammatory bowel disease: A machine learning approach.
Good clinical practice requires responsible conduct and considerations of safety and ethics.
Identifying interactions in omics data for clinical biomarker discovery using symbolic regression.
Combining symbolic regression with the Cox proportional hazards model improves prediction of heart failure deaths.
Meera shares how her passion for mathematics brought her to study physics and ultimately become a Data Scientist and AI Researcher at Abzu.
Symbolic regression analysis of interactions between first trimester maternal serum adipokines in pregnancies which develop pre-eclampsia.
Explainable “white-box” machine learning is the way forward in preeclampsia screening.
Our simple models accurately predicted and explained treatment responses for Checkmate Pharmaceuticals Abzu increased safe lead candidates by 20%
We're thrilled to announce that Gartner has named Abzu a "Cool Vendor" in AI for excelling in explainability, fairness, and trustworthiness.
Everyone seems to be talking about trustworthy AI these days. Yet it isn’t always clear what that is supposed to mean.
Abzu increased safe lead candidates by 20% for an undisclosed top-10 pharmaceutical company.
A recap of Abzu's Summer 2022 Beer, Data, + Drugs: An invite-only event to celebrate working in drug discovery.
An example of peptide drug featurization and modelling using anticancer peptides.
Let's study how well calibrated the QLattice models are, and to what extent calibrators can improve them.
What do machine learning model outputs represent? What if the predictions that we're making come with a future risk?
Calibrators are tools used to transform the scores generated by your models into (almost) real mathematical probabilities.
Something is brewing in Europe. Is it an ecosystem of excellence?
Om En Verden af Information: Kunstig intelligens (AI) skremmer, underholder og løser problemer. Men hvad er AI, hvordan virker den og hvad laver den i din svigermors mikroovn?
Mette Kirstine Agger will help Abzu strengthen its position in life science and biotech by building a bridge between research and business development with her special experience in how new technologies can create and support growth and business opportunities within biotech and a wide range of other lines of industries.
Abzu om Techtopia: Den kunstige intelligens skal ud af den sorte box, så vi kan forstå, hvordan den er nået til sit resultat, og hvad vi kan bruge det til.
Explainable long-term building energy consumption prediction using the QLattice.
In under 2 mins: Why we have to understand what the decisions we make are based on and not blindly trust that a computer is right.
On The Healthtech Podcast, Casper talks about how Abzu was founded, and everything healthcare and technology.
A 2-minute introduction to Abzu, how we apply our AI technology to drug discovery, and our partnership with CataloniaBio and HealthTech.
A 3 minute video about why Abzu was founded: To build a technology that approaches artificial intelligence in a new way.
The QLattice, a new explainable AI algorithm, can cut through the noise of omics data sets and point to the most relevant inputs and models.
Basel Area Business & Innovation, a non-profit agency dedicated to helping startups, institutions, and companies find business success in the Basel Area, was integral in supporting Abzu’s settlement and facilitating access to the thriving ecosystem.
The artificial intelligence deep tech startup identifies false news with its proprietary QLattice
Curing your data preprocessing blues: Automatic handling of categorical data and scaling
A 17 minute video about Abzu's origins and an impactful application of explainable AI in life science: diagnosing breast cancer mortality.
“Emerging Technologies for Healthcare” begins with an IoT-based solution for the automated healthcare sector which is enhanced to provide solutions with advanced deep learning techniques.
The increasing application of black-box models gives rise to a range of both ethical and scientific questions.
The two companies aim to have a rapid target screening application available this year, enabling Contera Pharma to advance better nucleic acid-based therapeutics towards clinic development.
Symbolic regression outperforms other models for small data sets.
An approach to symbolic regression using Feyn.
Prior to the record-breaking seed round in Denmark of € 5.8 M, Abzu raised a total of € 2.9 M. Abzu plans to accelerate commercialization within pharmaceutical drug discovery and mature its AI platform for application in other industry verticals.
How the QLattice explains the cellular toxicity of RNA-targeting drugs.
Abzu er de 100 % transparente ift. alt fra økonomi til bestyrelsesmateriale. Det her er deres iværksætterhistorie.
The transparent and explainable graph-based models from Abzu allow Byrd to precisely understand what inputs have been used to determine if content has been falsified.
Abzu’s proprietary innovation completely changes the way problems are solved by introducing a new standard of interpretability. This funding will be used for research and product development.
At Abzu, we’re for human-centric tech. We’re not for control by external agents, so we’ll never ask for anything we don’t need.
Data sciencey-sphere, I have big news. A radical new machine learning model has surfaced.
“My skepticism towards machine learning is that people apply very complicated models with lots of features to problems that are probably easier to solve. What I like about your product is that it takes into consideration that simpler models could also be a solution,” commented a user.
Explainable AI with the QLattice and feynplots
Do you think about machine learning? How about all the research put into self-driving cars or image recognition or natural language processing?
Abzu i Go Aften Danmark! 2 minutter om fremtidens arbejdsform og hvorfor alle skal være deres egen chef.
Copenhagen- and Barcelona-led startup Abzu® is creating a SaaS platform that automatically builds advanced AI solutions, bringing AI to a much broader space of customers.

Subscribe for
notifications from Abzu.

You can opt out at any time. We’re cookieless, and our privacy policy is actually easy to read.